All Stories

  1. Are biological drugs effective and safe in older severe asthmatics?

    Article • Expert Opinion on Drug Safety, April 2019, Taylor & Francis

    Salvatore Battaglia, Stefania Principe

  2. The use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics

    Article • Therapeutics and Clinical Risk Management, October 2016, Dove Medical Press

    Salvatore Battaglia

  3. Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients

    Article • Clinical Interventions in Aging, October 2013, Taylor & Francis

    Salvatore Battaglia

  4. Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations [Corrigendum]

    Article • Journal of Asthma and Allergy, May 2013, Taylor & Francis

    Salvatore Battaglia

  5. Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations

    Article • Journal of Asthma and Allergy, March 2013, Taylor & Francis

    Salvatore Battaglia

  6. Lung penetration and patient adherence considerations in the management of asthma: role of extra fine formulations

    Article • Journal of Asthma and Allergy, January 2013, Taylor & Francis

    Salvatore Battaglia

  7. Diagnosis of airway obstruction in the elderly: contribution of the SARA study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2012, Taylor & Francis

    Professor Claudio Sorino, Salvatore Battaglia

  8. Anti-inflammatory effects of pre-seasonal Th1-adjuvant vaccine to Parietaria judaica in asthmatics

    Article • Journal of Asthma and Allergy, March 2011, Taylor & Francis

    Salvatore Battaglia